Home/Filings/4/0001209191-14-053197
4//SEC Filing

QUESTCOR PHARMACEUTICALS INC 4

Accession 0001209191-14-053197

CIK 0000891288operating

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 8:43 PM ET

Size

12.6 KB

Accession

0001209191-14-053197

Insider Transaction Report

Form 4
Period: 2014-08-14
Transactions
  • Disposition to Issuer

    Common Stock

    2014-08-144,1830 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2014-08-1413,5300 total
    Exercise: $35.78Exp: 2022-02-14Common Stock (13,530 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2014-08-143,8030 total
    Exercise: $40.37Exp: 2022-05-09Common Stock (3,803 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2014-08-149,2030 total
    Exercise: $34.86Exp: 2023-05-23Common Stock (9,203 underlying)
Footnotes (4)
  • [F1]Pursuant to Agreement and Plan of Merger, dated April 5, 2014 (the "Merger Agreement"), by and among Mallinckrodt plc ("Mallinckrodt"), Quincy Merger Sub, Inc. and Questcor Pharmaceuticals, Inc. ("Questcor"), Mallinckrodt acquired Questcor in a merger transaction (the "Merger") which closed at 4:30 p.m. EST, on August 14, 2014 (the "Effective Time"). At the Effective Time, each share of Questcor common stock (except for certain shares defined in the Merger Agreement) converted into the right to receive, without interest, (a) $30.00 in cash and (b) 0.897 of an ordinary share of Mallinckrodt, in exchange for such share of Questcor common stock ("Merger Consideration").
  • [F2]Pursuant to terms of the Merger, at the Effective Time, each Questcor stock option, whether vested or unvested, held by Questcor non-employee directors converted into the right to receive the Merger Consideration with respect to each share of Company common stock subject to such option immediately prior to the effective time of the Merger, net of the applicable exercise price.
  • [F3]The stock option is exercisable and vests in equal monthly installments over 48 months from the grant date of February 15, 2012.
  • [F4]Fully exercisable.

Issuer

QUESTCOR PHARMACEUTICALS INC

CIK 0000891288

Entity typeoperating
IncorporatedCA

Related Parties

1
  • filerCIK 0000891288

Filing Metadata

Form type
4
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 8:43 PM ET
Size
12.6 KB